Schade D S, Eaton R P
J Clin Invest. 1975 Nov;56(5):1340-4. doi: 10.1172/JCI108212.
The present study was designed to test the hypothesis that physiological concentrations of glucagon may increase plasma ketone body concentration when sufficient free fatty acid substrate is available to support hepatic ketogenesis. Physiological elevations of plasma glucagon concentration were produced by a constant infusion of hormone, and increased plasma-free fatty acid availability was produced by simultaneous heparin injection to induce intravascular lipolysis. In the five insulin-dependent subjects studied, when plasma glucagon concentration remained at the normal basal level of 72+/-14 pg/ml during control saline infusion, the heparin-induced increase in free fatty acid availability resulted in approximately a 20% increase in plasma ketone body concentration. In contrast, when plasma glucagon concentration was elevated by hormone infusion to the physiological level of 215+/-35 pg/ml, the heparin-induced increases in free fatty acid availability resulted in approximately an 80% increase in plasma ketone body concentration. These results suggest that physiological elevations in plasma glucagon concentration may augment ketonemia in diabetic man when simultaneous elevations in plasma-free fatty acid arepresent.
当有足够的游离脂肪酸底物支持肝脏生酮作用时,生理浓度的胰高血糖素可能会增加血浆酮体浓度。通过持续输注激素使血浆胰高血糖素浓度生理性升高,同时注射肝素诱导血管内脂肪分解,以增加血浆游离脂肪酸的可利用性。在研究的5名胰岛素依赖型受试者中,在输注生理盐水对照期间,当血浆胰高血糖素浓度维持在72±14 pg/ml的正常基础水平时,肝素诱导的游离脂肪酸可利用性增加导致血浆酮体浓度升高约20%。相比之下,当通过激素输注使血浆胰高血糖素浓度升高至215±35 pg/ml的生理水平时,肝素诱导的游离脂肪酸可利用性增加导致血浆酮体浓度升高约80%。这些结果表明,当血浆游离脂肪酸同时升高时,血浆胰高血糖素浓度的生理性升高可能会加剧糖尿病患者的酮血症。